Results 31 to 40 of about 3,074 (210)
Development and validation of stability-indicating methods for determination of torsemide
Bulletin of the Chemical Society of Ethiopia, 2016 Four sensitive and precise methods for determination of torsemide in presence of its degradation product and in pharmaceutical formulation were developed and validated.
H. E. Zaazaa +3 more
doaj +1 more source
Journal of Veterinary Internal Medicine, 2020 Background Torasemide is a potent loop diuretic with potential to treat congestive heart failure (CHF) in dogs. Objective Evaluate the efficacy and safety of torasemide compared to furosemide in dogs with first occurrence of CHF caused by degenerative ...
Beatrice Besche +4 more
doaj +1 more source
Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives [PDF]
, 2017 Congestion is a fundamental clinical sign in patients with chronic heart failure (CHF). Diuretics are the mainstay treatment for congestion but, so far, no randomized trial has ever shown any beneficial effect of diuretics on mortality in patients with ...
Carubelli, Valentina +1 more
core +1 more source
Pharmaceutics, 2020 Parenteral nutrition (PN) admixtures are prone to interacting with drugs administered intravenously via a common catheter. This may cause a threat to a patient’s health and life.
Szymon Tomczak +2 more
doaj +1 more source
Minimal Change Disease in an Adult: A Case Report
Journal of Nepal Medical Association, 2022 Minimal change disease is an important cause of nephrotic syndrome in children, however, few cases are seen among adults. There is very little literature regarding the occurrence of minimal change disease in adults.
Shashank Neupane +5 more
doaj +1 more source
Use of short‐acting vs. long‐acting loop diuretics after heart failure hospitalization
ESC Heart Failure, 2022 Aims Furosemide, a short‐acting loop diuretic (SD), is the dominant agent prescribed for heart failure (HF) in clinical practice. However, accumulating data suggests that long‐acting loop diuretics (LD), such as torsemide or azosemide, might have more ...
Shohei Imaeda +11 more
doaj +1 more source
Journal of Nepal Medical Association, 2023 Introduction: Anti-hypertensive medications are prescribed for the management of high blood pressure which is the leading cause of mortality in chronic hemodialysis patients. The objective of our study was to find out the prevalence of anti-hypertensive
Lujaw Ratna Tuladhar +4 more
doaj +1 more source
Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review. [PDF]
, 2007 The increasing prevalence and poor prognosis associated with heart failure have prompted research to focus on improving quality of life (QoL) for heart failure patients.
McGee, Hannah +2 more
core +1 more source
Photosensitive Lichenoid Reaction to Torsemide-a Loop Diuretic [PDF]
Mayo Clinic Proceedings, 1997 Torsemide, a potent loop diuretic of the sulfonylurea class, has been available for clinical use in the United States since 1993. Adverse generalized and cutaneous reactions to this medication are uncommon and are usually mild and transient. In this article, we describe an 82-year-old man who had a photosensitive lichenoid reaction due to torsemide ...
D R, Byrd, I, Ahmed
openaire +2 more sources
Management of COVID-19 Related Myocarditis: A Systematic Review
Asian Journal of Medical Sciences, 2021 On January 7 in China, one patient was identified with a new corona virus in throat culture, and World Health Organization called it severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Şahbender Koç +6 more
doaj +1 more source